CD44 and neoplasm: Overall, the results of this study showed higher expression of cells positive for the selected TME biomarkers (FAK+, CD44+, HIF-1α+, and Ki67+) within tumor nests compared to tumor stroma in tumor resection specimens of EC patients after NRCHT+R.